FDA Clearance for 23andMe genetic test on Hereditary Prostate Cancer Marker
The clearance allows 23andMe to report on the G84E mutation in the HOXB13 gene, clinically shown to significantly increase the risk of developing pros…
Tag: Digital Health
Spotlight on: Frontiers Health 2021
Digital health is unlocking new avenues for innovation across life sciences, and industry leaders are keen to tap into the potential of this burgeonin…
23andMe: a clinical trial for Immuno-oncology Antibody
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”), a leading consumer genetics and research company, today announced…
Gartner’s 2022 technology trends predictions and how they reflect to healthcare industry
Gartner just recently introduced their top strategic technology trends for 2022. They are split into three categories: Engineering trust, Sculpting ch…
Vayyar to provide fall detection powered by touchless technology compatible with new Amazon Alexa Together service
Sensors based on 4D imaging radar can instantly identify falls, and prompt Alexa to ask if the user wants to call the Urgent Response emergency helpli…
Vinehealth: $5.5 million of investment to launch in the US
Vinehealth, a 2018-founded, London-based digital health startup that’s built an app offering personalized support for cancer patients while also makin…
Women’s Health: WHO launches a chatbot with messaging on breast cancer
Launched in October for Breast Cancer Prevention Month, WHO's interactive chatbot targets women and offers them inspiration to improve their personal …
Pear Therapeutics goes public on Nasdaq as Pear
BOSTON – December 3, 2021 – Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines,…
PrecisionOS: approved by FDA to market VR surgical planning tool
PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market InVisionOS™ a patient specific planning tool u…
Pear Therapeutics receives FDA Breaktrough Device Designation
Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announ…